H. Saito

Discipline

Psychologie (1)

Type de document

Articles (4)

Co-auteur

Date

Source

Mot-clé

Human beings (4) Cancer (4) thérapie (3) Treatment (3) Chemotherapy (3) Therapeutics (3) Poseidon (Greek deity) (3) Lungs--Cancer (3) Lungs (3) Chemotherapy (3) Use (3) test (2) danger (2) cancer (2) survie (2) Cancer (2) Survival (2) Patients (2) Adjustable rate mortgages (2) Immunotherapy (2) Immunoglobulins (2) Patients (2) Immunotherapy (2) tendance (1) temps (durée) (1) norme (1) spectacle (1) mise sous écran protecteur (1) recherche (1) qualité de vie (1)

Documents écrit par H. Saito (4) | parle de H. Saito (0)

A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study.
E.B. Garon et al.
Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
E.B. Garon et al.
An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles.
R.S. Bresalier et al.
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.
M.L. Johnson et al. (20 févr. 2023)